Results 1 to 10 of about 2,981,211 (119)
Clinical audit of current Helicobacter pylori treatment outcomes in Singapore
Singapore Medical Journal, 2022 Introduction: H. pylori eradication reduces the risk of gastric malignancies and peptic ulcer disease. First-line therapies include 14-day PAC (proton pump inhibitor [PPI], amoxicillin, clarithromycin) and PBMT (PPI, bismuth, metronidazole, tetracycline).
Tiing Leong Ang +5 more
doaj +1 more source
Therapeutic Effect of Apatinib in First-line Treatment of Advanced Liver Cancer
Zhongliu Fangzhi Yanjiu, 2021 Objective To explore the effect of apatinib in first-line treatment of advanced liver cancer. Methods Retrospective analysis was performed on 35 patients with advanced liver cancer treated in our department from July 2017 to January 2020.
KE Shaobo +5 more
doaj +1 more source
Cancer Treatment and Research Communications, 2022 Background: The advent of immunotherapies (I-O) and targeted therapies has transformed the treatment landscape in advanced non-small cell lung cancer (NSCLC).
Adam Lee +5 more
doaj +1 more source
Durability of first-line antiretroviral treatment in the Russian Federation: retrospective study
Журнал инфектологии, 2023 Objective. To assess durability of antiretroviral therapy in first line in HIV-infected patients in real clinical practice in the Russian Federation and determine association between basic clinical and demographic characteristics and durability of ...
N. V. Sizova +6 more
doaj +1 more source
First-Line Treatment of ALK-Positive NSCLC
healthbook TIMES. Oncology Hematology, 2019 Non-small cell lung cancer (NSCLC) patients with rearrangements in the anaplastic lymphocyte kinase (ALK) gene are highly sensitive to ALK tyrosine kinase inhibitors (TKIs) like alectinib. Here, the case of a 77-year-old male patient with newly diagnosed
Hasna Bouchaab
doaj +2 more sources
Moving beyond first-line treatment options for OCD [PDF]
Mental Health Clinician, 2022 OCD is characterized by obsessions and compulsions that cause distress, are time-consuming, and interfere with a patient's social, occupational, or other areas of functioning.
Chris Paxos, PharmD, BCGP, BCPS, BCPP
doaj +1 more source
MedComm, 2023 Pembrolizumab with cisplatin and 5‐fluorouracil showed survival benefit but relatively high occurrence of treatment‐related adverse events (TRAEs) for recurrent/metastatic oral squamous cell carcinoma (R/M OSCC). A more tolerable regime is needed.
Houyu Ju +9 more
doaj +1 more source
Chemotherapy in Pancreatic Cancer: A Systematic Review
Medicina, 2018 Background and Aim: Pancreatic cancer is one of the most fatal cancers. Cytotoxic chemotherapy remains the mainstream treatment for unresectable pancreatic cancer.
Leva Hajatdoost +4 more
doaj +1 more source
Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment
Case Reports in Dermatological Medicine, 2021 Sporotrichosis is a fungal infection endemic in Latin America and has been attributed to the thermodimorphic fungus of the genus Sporothrix. Transmission to humans occurs during a traumatic injury with soil or organic material; additionally, lesions ...
Walter Belda +2 more
doaj +1 more source
Immunotoxicity of pembrolizumab in patients with metastatic non-small cell lung cancer: A single-centre study [PDF]
Archive of OncologyBackground: Immunotherapy represents a new form of treatment that stimulates the immune system to destroy cancer cells. Pembrolizumab is a humanized monoclonal antibody that binds to the PD-1 programmed cell death receptor and blocks its interaction with
Stojanović Miloš, Bursać Daliborka
doaj +1 more source